Global Medicinal Cannabis Market to Surpass US$ 58,426.15 Million by 2030, Says Coherent Market Insights (CMI)
August 10, 2022 08:40 ET
|
CMI
Seattle, Aug. 10, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global medicinal cannabis market is estimated to be valued at US$ 10,180.17 Million in 2022 and is expected to...
Global Cannabidiol (CBD) Market Report 2022: Featuring Key Players Canopy Growth Corporation, High Tide, Aurora Pharmaceutical & others
August 03, 2022 05:58 ET
|
Research and Markets
Dublin, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The "Global Cannabidiol (CBD) Market: Analysis By Product, By Source, By End User, By Distribution Channel, By Region Size and Trends with Impact of...
Global Cannabidiol Oil Market Intelligence Report to 2027 - Featuring Aurora Cannabis, CBD Life UK, Endoca and Hempura Among Others
July 25, 2022 06:48 ET
|
Research and Markets
Dublin, July 25, 2022 (GLOBE NEWSWIRE) -- The "Cannabidiol Oil Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Cannabis Extract Market to Surpass US$ 32,597.2 Million by 2030, Says Coherent Market Insights (CMI)
July 20, 2022 08:40 ET
|
CMI
Seattle, July 20, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global cannabis extract market is estimated to be valued at US$ 9,125.8 million in 2022 and expected to exhibit...
Grapefruit USA, Inc. Executes Binding Letter of Intent to Acquire Diagnostic Lab Corporation, Inc., Secure New Financing
July 06, 2022 06:00 ET
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
Vantage Hemp Co. Submits a Drug Master File for CBD Distillate to the U.S. Food & Drug Administration
April 28, 2022 07:10 ET
|
Vantage Hemp
Greeley, Colorado, April 28, 2022 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”), further solidifies its position as an industry leader by its announcement of a Drug Master File...
Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass™ Time Release THC+CBD Delivery Cream
April 19, 2022 06:00 ET
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
Geocann and Averix Bio form a strategic partnership to supply the global marketplace with pharmaceutical API phytocannabinoid ingredients formulated with a clinically proven drug delivery system technology
April 13, 2022 09:04 ET
|
Geocann
FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Averix Bio that will bring U.S.-produced API phytocannabinoid ingredients and...
Theralogix is first to launch an NSF International certified CBD softgel powered by the clinically proven VESIsorb® technology
April 11, 2022 23:19 ET
|
Geocann
FORT COLLINS, Colo., April 11, 2022 (GLOBE NEWSWIRE) -- Geocann and Theralogix are proud to announce the successful launch of a cannabidiol (CBD) and beta-caryophyllene (BCP) softgel formulation...
CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results
March 31, 2022 16:05 ET
|
CV Sciences, Inc.
SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...